Related Experiment Video

Updated: Jun 4, 2026

Tracking Drug-induced Changes in Receptor Post-internalization Trafficking by Colocalizational Analysis
07:48

Tracking Drug-induced Changes in Receptor Post-internalization Trafficking by Colocalizational Analysis

Published on: July 3, 2015

Modulating micro-opioid receptor phosphorylation switches agonist-dependent signaling as reflected in PKCepsilon

Hui Zheng1, Ji Chu, Yuhan Zhang

  • 1Department of Pharmacology, University of Minnesota, Minneapolis, Minnesota 55455-0217, USA. zhenhui2055@hotmail.com

The Journal of Biological Chemistry
|February 5, 2011
PubMed

Insights

G protein-coupled receptor (GPCR) phosphorylation dictates signaling pathways. Blocking OPRM1 phosphorylation shifts agonist responses, revealing phosphorylation

Area of Science:

  • Pharmacology
  • Molecular Biology
  • Neuroscience

Background:

  • G protein-coupled receptors (GPCRs) are crucial drug targets.
  • Receptor phosphorylation is known to regulate GPCR function.
  • The specific role of GPCR phosphorylation in differential agonist signaling remains incompletely understood.

Purpose of the Study:

  • To elucidate the novel role of G protein-coupled receptor (GPCR) phosphorylation in differential agonist signaling using the μ-opioid receptor (OPRM1) as a model.
  • To investigate how OPRM1 phosphorylation influences pathway selection (PKCε vs. β-arrestin2) and downstream cellular responses.

Main Methods:

  • Utilized OPRM1 phosphorylation site mutants to block phosphorylation.
  • Employed pathway activation assays (PKCε and ERK phosphorylation).
  • Assessed β-arrestin2 recruitment and GRK2 overexpression effects.
  • Examined agonist-induced changes in dendritic spine stability in hippocampal neurons.

Main Results:

  • Morphine induced low OPRM1 phosphorylation, activating PKCε, while etorphine, fentanyl, and DAMGO induced extensive phosphorylation via β-arrestin2.
  • Blocking OPRM1 phosphorylation enabled etorphine, fentanyl, and DAMGO to activate the PKCε pathway.
  • Receptor phosphorylation was essential for differential agonist effects on dendritic spine stability, with phosphorylation blockage mimicking morphine's effects.

Conclusions:

  • Agonist-dependent phosphorylation of GPCRs critically regulates the activation of specific signaling pathways, such as the PKC pathway.
  • GPCR phosphorylation dictates downstream cellular responses, including receptor desensitization and effects on neuronal morphology.
  • This study reveals a key mechanism by which GPCRs achieve diverse signaling outcomes based on agonist properties and receptor modification.

More Related Videos

Visualizing Protein Kinase A Activity In Head-fixed Behaving Mice Using In Vivo Two-photon Fluorescence Lifetime Imaging Microscopy10:41

Visualizing Protein Kinase A Activity In Head-fixed Behaving Mice Using In Vivo Two-photon Fluorescence Lifetime Imaging Microscopy

Published on: June 7, 2019

Related Concept Videos

Opioid Receptors: Overview01:22

Opioid Receptors: Overview

Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2, D-Pen5]-enkephalin or DPDPE for...
Analgesia and Pain Management01:25

Analgesia and Pain Management

Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
GPCR Desensitization01:12

GPCR Desensitization

G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...
Calmodulin-dependent Signaling01:16

Calmodulin-dependent Signaling

Calmodulin (CaM) is a calcium-binding protein in eukaryotes that controls various calcium-regulated cellular processes. It has four calcium-binding sites that bind calcium to form the calcium-calmodulin ( Ca2+-CaM) complex. GPCR stimulation increases the calcium levels in the cells that bind to CaM and induces a conformational change.
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
GPCRs Regulate Adenylyl Cylase Activity01:09

GPCRs Regulate Adenylyl Cylase Activity

Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of cells.
Two...